(Q36589164)

15 August 2017

1 reference

title

Cellular pathology in multiple system atrophy (English)

1 reference

15 August 2017

Koichi Wakabayashi

1

1 reference

PubMed ID

16961071

15 August 2017

Hitoshi Takahashi

series ordinal

2

1 reference

15 August 2017

1 August 2006

1 reference

15 August 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Neuropathology

1 reference

15 August 2017

26

1 reference

15 August 2017

4

1 reference

15 August 2017

338-345

1 reference

A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Argyrophilic glial intracytoplasmic inclusions in multiple system atrophy: immunocytochemical and ultrastructural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Olfactory bulb in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Immunohistochemical expression of microtubule-associated protein 5 (MAP5) in glial cells in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 1. Neuronal cytoplasmic inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Neuronal inclusions in the dentate fascia in patients with multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Distribution and dynamic process of neuronal cytoplasmic inclusion (NCI) in MSA: correlation of the density of NCI and the degree of involvement of the pontine nuclei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Pathology of the inferior olivary nucleus in patients with multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Multiple system atrophy: a review of 203 pathologically proven cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Multiple system atrophy with remarkable frontal lobe atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Decrease of neurons in the medullary arcuate nucleus of multiple system atrophy: quantitative comparison with Parkinson's disease and amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Involvement of precerebellar nuclei in multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Involvement of medullary serotonergic groups in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

"Minimal change" multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

An autopsy case of early ("minimal change") olivopontocerebellar atrophy (multiple system atrophy-cerebellar).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Myelin degeneration in multiple system atrophy detected by unique antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Mice expressing the alpha(1B)-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00713.X

10.1111/J.1440-1789.2006.00713.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16961071